---
name: >-
  à¸›à¸£à¸°à¸à¸²à¸¨à¸„à¸“à¸°à¸à¸£à¸£à¸¡à¸à¸²à¸£à¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œà¸•à¸²à¸¡à¸žà¸£à¸°à¸£à¸²à¸Šà¸šà¸±à¸à¸à¸±à¸•à¸´à¸›à¸£à¸°à¸à¸±à¸™à¸ªà¸±à¸‡à¸„à¸¡ à¹€à¸£à¸·à¹ˆà¸­à¸‡
  à¸«à¸¥à¸±à¸à¹€à¸à¸“à¸‘à¹Œà¹à¸¥à¸°à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸šà¸£à¸´à¸à¸²à¸£à¸—à¸²à¸‡à¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œà¸ªà¸³à¸«à¸£à¸±à¸šà¸à¸²à¸£à¸•à¸£à¸§à¸ˆà¸„à¸±à¸”à¸à¸£à¸­à¸‡à¹à¸¥à¸°à¸§à¸´à¸™à¸´à¸ˆà¸‰à¸±à¸¢à¹‚à¸£à¸„
  à¹à¸¥à¸°à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸£à¸±à¸à¸©à¸²à¸§à¸±à¸“à¹‚à¸£à¸„à¸”à¸·à¹‰à¸­à¸¢à¸²
date: '2023-11-21'
category: à¸‡ à¸žà¸´à¹€à¸¨à¸©
volume: 140
section: 292
page: 4
source: 'https://ratchakitcha.soc.go.th/documents/12164.pdf'
draft: true
---

# à¸›à¸£à¸°à¸à¸²à¸¨à¸„à¸“à¸°à¸à¸£à¸£à¸¡à¸à¸²à¸£à¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œà¸•à¸²à¸¡à¸žà¸£à¸°à¸£à¸²à¸Šà¸šà¸±à¸à¸à¸±à¸•à¸´à¸›à¸£à¸°à¸à¸±à¸™à¸ªà¸±à¸‡à¸„à¸¡ à¹€à¸£à¸·à¹ˆà¸­à¸‡ à¸«à¸¥à¸±à¸à¹€à¸à¸“à¸‘à¹Œà¹à¸¥à¸°à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸šà¸£à¸´à¸à¸²à¸£à¸—à¸²à¸‡à¸à¸²à¸£à¹à¸žà¸—à¸¢à¹Œà¸ªà¸³à¸«à¸£à¸±à¸šà¸à¸²à¸£à¸•à¸£à¸§à¸ˆà¸„à¸±à¸”à¸à¸£à¸­à¸‡à¹à¸¥à¸°à¸§à¸´à¸™à¸´à¸ˆà¸‰à¸±à¸¢à¹‚à¸£à¸„ à¹à¸¥à¸°à¸­à¸±à¸•à¸£à¸²à¸„à¹ˆà¸²à¸£à¸±à¸à¸©à¸²à¸§à¸±à¸“à¹‚à¸£à¸„à¸”à¸·à¹‰à¸­à¸¢à¸²

)1>@0à¸„!>11/@1@1Oà¸ž%0à¹Œ#@/à¸ž1>1@(??#>)1>?'2?à¸„/ N1APà¸­ à¸«3?N!à¹ŒO3>à¸­?#1@à¸„N@(1>@1%@@1Oà¸ž%0à¹Œ2à¹@à¸«1?(@1#1/à¸„?"1à¸­O3>/>'>?0/?!P1à¸„ O3>à¸­?#1@à¸„N@1?1@/?!P1à¸„"AQà¸­0@ P"0%?PN)à¹‡'@12/à¸„/1à¹@à¸«'"à¸«3?N!à¹ŒO3>à¸­?#1@à¸„N@(1>@1%@@1Oà¸ž%0à¹Œ 2à¹@à¸«1?(@1#1/à¸„?"1à¸­ O3>/>'>?0/?!P1à¸„ON*CO)1>?'#'%?PR/N/?2?@#>R%0 O3>à¸­?#1@à¸„N@1?1@/?!P1à¸„"AQà¸­0@à¸­*CO)1>?'#' Nà¸žAPà¸­Qà¸«O*CO)1>?'#'%?P)à¹ˆ/0"O/0P1à¸„/?!P1à¸„2@/@1$NO@$@(1>@1%@@1Oà¸ž%0à¹ŒR"Oà¸­0N@Nà¸«/@>2/ O3>/?)1>2>%&>.@à¸ž #@//#>à¸„!>11/@1@1Oà¸ž%0à¹Œ Q'@1)1>B/à¸„1?Q%?P 2/2566 N/APà¸­/?'%?P 5 N/1@0' 2566 O3>à¸„1?Q%?P 4/2566 N/APà¸­/?'%?P 14 />$B'@0' 256 ` P"0à¸„/@/Nà¸«O'à¸­(à¸­ à¸„!>11/@1)1>?'2?à¸„/ ( B"%?P 13) Q'@1)1>B/à¸„1?Q%?P 14/2566 N/APà¸­/?'%?P 21 1@à¸„/ 2566 à¸­@0?0à¸­à¹@'@#@/à¸„/@/Q'/@#1@ 15 (2) O3>/@#1@ 63 Oà¸«Nà¸ž1>1@(??#>)1>?'2?à¸„/ à¸ž . 0 . 2533 @POORNà¸ž>P/N#>/P"0à¸ž1>1@(??#>)1>?'2?à¸„/ ( (?(%?P 4) à¸ž . 0 . 2558 à¸„!>11/@1@1Oà¸ž%0à¹ŒP"0à¸„/@/Nà¸«O'à¸­(à¸­à¸„!>11/@1)1>?'2?à¸„/ @à¸­à¸­)1>@0R/O "?#Nà¸­R)'?Q Oà¸­ 1 )1>@0(?('?QQà¸«OQO(?à¸„?(#?QO#N(?"'?QN)à¹‡'#O'R) Oà¸­ 2 Q')1>@0'?Q Ã¬ 2à¹@'?@' Ã® à¸«/@0à¸„/@//N@ 2à¹@'?@')1>?'2?à¸„/ Ã¬ 2$@'à¸ž0@(@3 Ã® à¸«/@0à¸„/@//N@ 2$@'à¸ž0@(@3%?P2à¹@'?@'à¹@à¸«'"2>%&>Q'@11?((1>@1 %@@1Oà¸ž%0à¹Œ2à¹@à¸«1?(*CO)1>?'#' Ã¬ @1#1/à¸„?"1à¸­/?!P1à¸„ Ã® à¸«/@0à¸„/@//N@ @1#1/à¸„?"1à¸­O3>/>'>?0/?!P1à¸„Q'*CO)1>?'#' %?P/?à¸„/@/N2?P02C#Nà¸­/?!P1à¸„ 7 3BN/N2?P0 R"OON (1) *CO2?/*?2*CO)à¹ˆ/0/?!P1à¸„)à¸­" (2) *CO#Oà¸­? *COà¸­@0?0Q'2$@'à¸„BO/à¸„1à¸­O3>à¸ž? '@à¸„'à¸ž>@1 / 2$@'à¸„BO/à¸„1à¸­à¸„'R1O%?Pà¸ž@P (3) *CO#>"NAQà¸­Nà¸­Rà¸­/? (4) *CO)à¹ˆ/0P1à¸„%?P%à¹@Qà¸«O.C/>à¸„BO/?'3"3 R"OON *CO)à¹ˆ/0N(@à¸«/@'%?Pà¸„/(à¸„B/1>"?('Qà¹@#@3R/NR"O (HbA 1 c /@/N@ à¸«1Aà¸­N%N@?( 7 mg%) *CO)à¹ˆ/0P1à¸„R#N1AQà¸­1? à¸«1Aà¸­R"O1?(0@".C/>à¸„BO/?' (5) *CO2Cà¸­@0B/@/N@à¸«1Aà¸­N%N@?( 65 )à¸µ %?P2C((Bà¸«1?P à¸«1Aà¸­/?P1à¸„1N// )à¸­"à¸­B"?Q'N1AQà¸­1? à¸«1Aà¸­/?P1à¸„1N//N(@à¸«/@' (6) *COQO2@1N2à¸ž#>" #>"2B1@N1AQà¸­1? (7) (Bà¸„3@12@&@1!2B Ã¬ /?!P1à¸„"AQà¸­0@à¸«3@0'@' Ã® à¸«/@0à¸„/@//N@ NAQà¸­/?!P1à¸„%?P"AQà¸­#Nà¸­0@ Isoniazid O3> Rifampicin N)à¹‡'à¸­0N@'Oà¸­0 à¸«à¸™à¹‰à¸² 4 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 292 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 21 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

Ã¬ 0@1?1@/?!P1à¸„"AQà¸­0@ Ã® à¸«/@0à¸„/@//N@ 0@1?1@/?!P1à¸„"AQà¸­0@à¸«3@0'@'"O/02C#10@1>0>2?Q' Oral STR (Oral Shorter regimen) 4-6 Bdq (6 N"Aà¸­' )-Lfx(Mfx)-Pto(Eto)-Cfz-Z-E-H high-dose / 5.Lfx(Mfx)-Cfz-Z-E #@//@#1@'%?P1/à¸„/(à¸„B/P1à¸„ 1>%1/2@&@1!2Bà¹@à¸«'" Qà¸«O?(*CO)1>?'#' %?PR"O1?(@1/>'>?0/N@N)à¹‡'*CO)à¹ˆ/0/?!P1à¸„"AQà¸­0@ (MDR/RR-TB) P"0R/N/?.@/>"AQà¸­0@3BN/ FQs O3>N)à¹‡'R)#@/ N!à¹Œ@1à¸„?"N3Aà¸­*CO)à¹ˆ/0%?PNà¸«/@>2/à¸­à¸­/?!P1à¸„ 1/à¸„/(à¸„B/P1à¸„à¹@à¸«'" Oà¸­ 3 Qà¸«O2à¹@'?@'N@0à¸„N@(1>@1%@@1Oà¸ž%0à¹ŒON2$@'à¸ž0@(@3 "?'?Q  . à¸„N@@1#1/à¸„?"1à¸­/?!P1à¸„ON*CO)1>?'#'%?PR/N/?2?@#>R%0%?P/?à¸„/@/N2?P02C#Nà¸­/?!P1à¸„ 7 3BN/N2?P0 #@/à¸«3?N!à¹ŒO'(%O@0)1>@0'?Q  . à¸„N@0@1?1@/?!P1à¸„"AQà¸­0@ à¸ž>@1!@@1@0@10@%?PQO#@/#@1@à¸„N@0@1?1@/?!P1à¸„"AQà¸­0@ "O/02C#10@1>0>2?Q' O'(%O@0)1>@0 Q'à¸­?#1@ "?'?Q 1. 2C#10@1>0>2?Q' 6 Bdq-Mfx-Pto-Cfz-Z-H high-dose -E/5 Mfx-Cfx-Z-E 1!?%?P 1 1!?%?PN2/à¸«>N"Aà¸­'%?P 4 /?*33( 1>0>NO/O' 4 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 70,100 (@% 1!?%?P 2 1!?%?PN2/à¸«>N"Aà¸­'%?P ^ /?*3(/ 1>0>NO/O' 6 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 78,200 (@% 2. 2C#10@1>0>2?Q' 6 Bdq-Mfx-Eto-Cfz-Z-H high-dose -E/5 Mfx-Cfx-Z-E 1!?%?P 1 1!?%?PN2/à¸«>N"Aà¸­'%?P 4 /?*33( 1>0>NO/O' 4 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 78,200 (@% 1!?%?P 2 1!?%?PN2/à¸«>N"Aà¸­'%?P ^ /?*3(/ 1>0>NO/O' 6 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 90,300 (@% 3. 2C#10@1>0>2?Q' 6 Bdq-Lfx-Eto-Cfz-Z-H high-dose -E/5 Lfx-Cfx-Z-E 1!?%?P 1 1!?%?PN2/à¸«>N"Aà¸­'%?P 4 /?*33( 1>0>NO/O' 4 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 59,100 (@% 1!?%?P 2 1!?%?PN2/à¸«>N"Aà¸­'%?P ^ /?*3(/ 1>0>NO/O' 6 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 67,000 (@% 4. 2C#10@1>0>2?Q' 6 Bdq-Lfx-Pto-Cfz-Z-H high dose -E/5 Lfx-Cfx-Z-E 1!?%?P 1 1!?%?PN2/à¸«>N"Aà¸­'%?P 4 /?*33( 1>0>NO/O' 4 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 51,000 (@% 1!?%?P 2 1!?%?PN2/à¸«>N"Aà¸­'%?P ^ /?*3(/ 1>0>NO/O' 6 N"Aà¸­' 1>0>#Nà¸­N'APà¸­ 5 N"Aà¸­' Q'à¸­?#1@N%N@%?PN@01>R/NN>' 54,800 (@% %?Q'?Q 2$@'à¸ž0@(@32@/@1$QO0@ Moxifloxacin (Mfx) O%'0@ Levofloxacin (Lfx) R"O O3>QO0@ Ethionamide (Eto) O%'0@ Prothionamide (Pto) R"O à¸«à¸™à¹‰à¸² 5 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 292 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 21 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

Oà¸­ 4 *CO)1>?'#'%?P/?2?@#>R%0Qà¸«OR"O1?(2>%&>@1#1/à¸„?"1à¸­/?!P1à¸„Q'à¸«'N/0(1>@1 2@&@1!2BQ'1>((à¸«3?)1>?'2B.@à¸žOà¸«N@#> à¸«1Aà¸­Q'2$@'à¸ž0@(@3 P"0Qà¸«O2$@'à¸ž0@(@3N(>à¸„N@ @1#1/à¸„?"1à¸­/?!P1à¸„@2à¹@'?@'à¸«3?)1>?'2B.@à¸žOà¸«N@#> O3>Qà¸«O2à¹@'?@'OO2$@'à¸ž0@(@3 Nà¸žAPà¸­@Q'%>N(?0'N)à¹‡'à¸«'N/0(1>@11!?@1#1/à¸„?"1à¸­/?!P1à¸„Q'1>((à¸«3?)1>?'2B.@à¸žOà¸«N@#> Oà¸­ 5 Qà¸«O2$@'à¸ž0@(@31@0@'Oà¸­/C3*N@'1>((P)1O1/1@0@'Oà¸­/C3/?!P1à¸„à¸­)1>N%0R%0 (National Tuberculosis Information Program : NTIP) à¸­à¸­/?!P1à¸„ 1/à¸„/(à¸„B/P1à¸„ )1>@0 ! /?'%?P 1 à¸ž20>@0' à¸ž . 0 . 2_` 6 à¸ž3#à¹@1/P% &'@ &B1>N' )1>&@'11/@1@1Oà¸ž%0à¹Œ à¸«à¸™à¹‰à¸² 6 à¹€à¸¥ïœŠà¸¡ 140 à¸•à¸­à¸™à¸žà¸´à¹€à¸¨à¸© 292 à¸‡ à¸£à¸²à¸Šà¸à¸´à¸ˆà¸ˆà¸²à¸™à¸¸à¹€à¸šà¸à¸©à¸² 21 à¸žà¸¤à¸¨à¸ˆà¸´à¸à¸²à¸¢à¸™ 2566

1 à¸«à¸¥?Nà¹ŒO!"O@0#1>@0 .à¹à¸²à¸«1?&à¹à¸²1!1/à¸„? 1à¸­/?P1à¸„ ON(CO'1>?%!%#?NR/N/?.?à¸à¹à¸²!>R#0#?N/?à¸„/à¹à¸²/N.?N0.C!Nà¸­/?P1à¸„ 7 à¸¥BN/N.?N0 1à¹à¸²0à¹à¸²1 à¸­?!1à¹à¸²à¹à¸²1Nà¹à¸²0 1. à¹à¸²1!1/#à¹à¸²à¸«Oà¸­'à¸>&?!>à¹à¸²1Nà¸žANà¸­à¸„? 1à¸­/?P1à¸„Q%à¸¥BN/N.?N0 à¸„N@#1/ Chest X - ray Q'à¸­?#1@N%N@%?PN@01>R/NN>' 100 (@%#Nà¸­à¸„1?Q (R/NN>' 1 à¸„1?Q#Nà¸­à¸„'#Nà¸­)à¸µ) 2 . à¹à¸²1!1/Nà¸žANà¸­/>%>?0Oà¸¥>!1/à¸«à¹à¸²NAOà¸­ A O à¸­0à¹à¸² 2.1 à¸„N@/>'>?0/?!P1à¸„//?!P1à¸„"AQà¸­0@ First - line drug R/NN>' 1 à¸„1?Q#Nà¸­à¸„'#Nà¸­)à¸µ ( 1 ) TB - LAMP />'>?0/?!P1à¸„/#1/à¸«@NAQà¸­ MTB Q'à¸­?#1@N%N@%?PN@01>R/NN>' 200 (@%#Nà¸­à¸„1?Q ( 2 ) Real - time PCR ( Xpert MTB / RIF ) N@01//Q'à¸­?#1@ 5 00 (@%#Nà¸­à¸„1?Q - à¸„N@/>'>?0/?!P1à¸„/#1/à¸«@NAQà¸­ MTB Q'à¸­?#1@N%N@%?PN@01>R/NN>' 400 (@%#Nà¸­à¸„1?Q - à¸„N@#1/à¸«@NAQà¸­"AQà¸­0@ Rifampicin ('>"N"?0/) Q'à¸­?#1@N%N@%?PN@01>R/NN>' 1 00 (@%#Nà¸­à¸„1?Q (3) Real - time PCR MTB / MDR ( Anyplex ) N@01//Q'à¸­?#1@ 6 00 (@%#Nà¸­à¸„1?Q - à¸„N@/>'>?0/?!P1à¸„/#1/à¸«@NAQà¸­ MTB Q'à¸­?#1@N%N@%?PN@01>R/NN>' 400 (@%#Nà¸­à¸„1?Q - #1/à¸«@NAQà¸­"AQà¸­0@ INH + Rifampicin ( 2 '>") N%N@%?PN@01>R/NN>' 200 (@%#Nà¸­à¸„1?Q ( 4 ) Line Probe Assay ( LPA ) N@01//Q'à¸­?#1@ 6 00 (@%#Nà¸­à¸„1?Q - à¸„N@/>'>?0/?!P1à¸„/#1/à¸«@NAQà¸­ MTB Q'à¸­?#1@N%N@%?PN@01>R/NN>' 400 (@%#Nà¸­à¸„1?Q - à¸„N@#1/à¸«@NAQà¸­"AQà¸­0@ INH + Rifampicin ( 2 '>") Q'à¸­?#1@N%N@%?PN@01>R/NN>' 200 (@%#Nà¸­à¸„1?Q ***.à¹à¸²à¸«1?&à¹à¸²1!1/!à¹à¸²/Oà¸­ 2.1 (2) (3) (4) Qà¸«ONà¸¥Aà¸­!1/ O /0/>$?Q />$?à¸«%@N 2 . 2 à¸„N@/>'>?0/?!P1à¸„"AQà¸­0@ Second - line drugs R/NN>' 1 à¸„1?Q#Nà¸­à¸„'#Nà¸­)à¸µ (1) Line Probe Assay ( FQ O3> AG / CP ) Q'à¸­?#1@N%N@%?PN@01>R/NN>' 700 (@%#Nà¸­à¸„1?Q (2) Real - time PCR MTB / XDR ( FQ O3> AG / CP ) 3. 1?."à¹à¸²%à¸ž0à¹à¸²&à¹à¸²à¸¥#?N0?R/Nà¸ž1Oà¸­/ O à¹à¸²%0?0.à¹à¸²à¸žQ%à¹à¸²1!1/ Molecular Assay 3 . 1 à¸„N@#1/"O/0/>&? AFB Q'à¸­?#1@N%N@%?PN@01>R/NN>' 20 (@%#Nà¸­à¸„1?Q (R/NN>' 3 à¸„1?Q#Nà¸­à¸„'#Nà¸­)à¸µ) 3 . 2 à¸„N@#1/"O/0/>&?Nà¸ž@>N3?Q0NAQà¸­ Culture R/NN>' 1 à¸„1?Q#Nà¸­à¸„'#Nà¸­)à¸µ (1) à¸„N@N%à¸„'>à¸„ Solid Media Q'à¸­?#1@N%N@%?PN@01>R/NN>' 200 (@%#Nà¸­#?/à¸­0N@ (2) à¸„N@N%à¸„'>à¸„ Liquid Media Q'à¸­?#1@N%N@%?PN@01>R/NN>' 300 (@% #Nà¸­#?/à¸­0N@

2 à¸„N@0@1?1@/?P1à¸„ ? O à¸­0@ O /02A!10@1>0>2?O! Oral STR ( Oral Shorter regimen ) 4 - 6 Bdq (6 N ? à¸­!) - Lfx ( Mfx ) - Pto ( Eto ) - Cfz - Z - E - H high - dose /5 Lfx ( Mfx ) - Cfz - Z - E !@//@!1@!?N1/à¸„/"à¸„@/P1à¸„ 1>1/2@ @12@ @à¸«! ** 1?à¸—?P 1 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥à¸¥ Qà¸«O1? 0@1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 9 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 4 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Moxifloxacin (Mfx) 400 mg 1 1.5 2 120 150 270 45 Prothionamide (Pto) 250 mg 1 2 3 120 0 120 2.46 Clofazimine (Cfz) 50 mg 1 0 0 120 150 270 25 Clofazimine (Cfz) 100 mg 0 1 1 120 150 270 29.47 Pyrazinamide (Z) 500 mg 2 3 4 120 150 270 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 120 0 120 0.6 Isoniazid (H high-dose ) 100 mg 1 120 0 120 0.19 Ethambutol (E) 400 mg 2 2 3 120 150 270 0.89 Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 1. 2à¸¹!10@ 6Bdq- Mfx - Pto -Cfz-Z-H high-dose -E/5 Mfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ

3 ** 1?à¸—?P 2 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥ /Oà¸¥>0@0@11?1@1>0>NO/Oà¸­? 2 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 11 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 6 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Moxifloxacin (Mfx) 400 mg 1 1.5 2 180 150 330 45 Prothionamide (Pto) 250 mg 1 2 3 180 0 180 2.46 Clofazimine (Cfz) 50 mg 1 0 0 180 150 330 25 Clofazimine (Cfz) 100 mg 0 1 1 180 150 330 29.47 Pyrazinamide (Z) 500 mg 2 3 4 180 150 330 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 180 0 180 0.6 Isoniazid (H high-dose ) 100 mg 1 180 0 180 0.19 Ethambutol (E) 400 mg 2 2 3 180 150 330 0.89 Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 1. 2à¸¹!10@ 6Bdq- Mfx - Pto -Cfz-Z-H high-dose -E/5 Mfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ

4 ** 1?à¸—?P 1 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥à¸¥ Qà¸«O1? 0@1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 9 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 4 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Moxifloxacin (Mfx) 400 mg 1 1.5 2 120 150 270 45 Ethionamide (Eto) 250 mg 1 2 3 120 0 120 25 Clofazimine (Cfz) 50 mg 1 0 0 120 150 270 25 Clofazimine (Cfz) 100 mg 0 1 1 120 150 270 29.47 Pyrazinamide (Z) 500 mg 2 3 4 120 150 270 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 120 0 120 0.6 Isoniazid (H high-dose ) 100 mg 1 120 0 120 0.19 Ethambutol (E) 400 mg 2 2 3 120 150 270 0.89 Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 2. 2à¸¹!10@ 6Bdq- Mfx - Eto -Cfz-Z-H high-dose -E/5 Mfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ

5 ** 1?à¸—?P 2 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥ /Oà¸¥>0@0@11?1@1>0>NO/Oà¸­? 2 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 11 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 6 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Moxifloxacin (Mfx) 400 mg 1 1.5 2 180 150 330 45 Ethionamide (Eto) 250 mg 1 2 3 180 0 180 25 Clofazimine (Cfz) 50 mg 1 0 0 180 150 330 25 Clofazimine (Cfz) 100 mg 0 1 1 180 150 330 29.47 Pyrazinamide (Z) 500 mg 2 3 4 180 150 330 0.98 Isoniazid (-H high-dose ) 300 mg 1 1 2 180 0 180 0.6 Isoniazid (-H high-dose ) 100 mg 1 180 0 180 0.19 Ethambutol (E) 400 mg 2 2 3 180 150 330 0.89 2. 2à¸¹!10@ 6Bdq- Mfx - Eto -Cfz-Z-H high-dose -E/5 Mfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@

6 ** 1?à¸—?P 1 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥à¸¥ Qà¸«O1? 0@1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 9 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 4 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Levofloxacin (Lfx) 500 mg 1 1.5 2 120 150 270 9.65 Ethionamide (Eto) 250 mg 1 2 3 120 0 120 25 Clofazimine (Cfz) 50 mg 1 0 0 120 150 270 25 Clofazimine (Cfz) 100 mg 0 1 1 120 150 270 29.47 Pyrazinamide (Z) 500 mg 2 3 4 120 150 270 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 120 0 120 0.6 Isoniazid (H high-dose ) 100 mg 1 120 0 120 0.19 Ethambutol (E) 400 mg 2 2 3 120 150 270 0.89 Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 3. 2à¸¹!10@ 6Bdq- Lfx - Eto -Cfz-Z-H high-dose -E/5 Lfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ

7 ** 1?à¸—?P 2 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥ /Oà¸¥>0@0@11?1@1>0>NO/Oà¸­? 2 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 11 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 6 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Levofloxacin (Lfx) 500 mg 1 1.5 2 180 150 330 9.65 Ethionamide (Eto) 250 mg 1 2 3 180 0 180 25 Clofazimine (Cfz) 50 mg 1 0 0 180 150 330 25 Clofazimine (Cfz) 100 mg 0 1 1 180 150 330 29.47 Pyrazinamide (Z) 500 mg 2 3 4 180 150 330 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 180 0 180 0.6 Isoniazid (H high-dose ) 100 mg 1 180 0 180 0.19 Ethambutol (E) 400 mg 2 2 3 180 150 330 0.89 Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 3. 2à¸¹!10@ 6Bdq- Lfx - Eto -Cfz-Z-H highdose -E/5 Lfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ

8 ** 1?à¸—?P 1 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥à¸¥ Qà¸«O1? 0@1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 9 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 4 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Levofloxacin (Lfx) 500 mg 1 1.5 2 120 150 270 9.65 Prothionamide (Pto) 250 mg 1 2 3 120 0 120 2.46 Clofazimine (Cfz) 50 mg 1 0 0 120 150 270 25 Clofazimine (Cfz) 100 mg 0 1 1 120 150 270 29.47 Pyrazinamide (Z) 500 mg 2 3 4 120 150 270 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 120 0 120 0.6 Isoniazid (H high-dose ) 100 mg 1 120 0 120 0.19 Ethambutol (E) 400 mg 2 2 3 120 150 270 0.89 24 à¸­à¸²à¸—à¸´0à¹Œ Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ 4. 2à¸¹!10@ 6Bdq- Lfx - Pto -Cfz-Z-H high-dose -E/5 Lfx -Cfx-Z-E

9 ** 1?à¸—?P 2 Q1?à¸—?PN2/à¸«>N à¸· à¸­à¸—?P 4 /?"à¸¥ /Oà¸¥>0@0@11?1@1>0>NO/Oà¸­? 2 N à¸· à¸­ 1//1>0>N/à¸¥@@11?1@N!à¹‡ 11 N à¸· à¸­ 1@0à¸·Pà¸­0@ @ 0@ à¹‰@à¸«?Oà¸­0/N@ 30 >Pà¸¥1?/ à¹‰@à¸«? 30-50 >Pà¸¥1?/ à¹‰@à¸«?/@/N@ 50 >Pà¸¥1?/ à¹‰@//? 1>0>NO/O 6 N à¸· à¸­ à¹‰@//? 1>0>!Nà¸­Nà¸·Pà¸­ 5 N à¸· à¸­ à¹‰@/0@à¸—?P R O 1? à¸—?à¸«/ ( N/O / Oà¸„!à¸¹à¸¥ ) 1@à¸„@0@!Nà¸­ à¸«N/0 ( @à¸— ) Bedaquile (Bdq) 100 mg 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 4 N/à¹‡ (2 à¸­à¸²à¸—à¸´0à¹Œ ) Oà¸¥à¸° 2 N/à¹‡ à¸ˆ à¸ž à¸¨ (22 à¸­à¸²à¸—à¸´0à¹Œ ) 188 186 Levofloxacin (Lfx) 500 mg 1 1.5 2 180 150 330 9.65 Prothionamide (Pto) 250 mg 1 2 3 180 0 180 2.46 Clofazimine (Cfz) 50 mg 1 0 0 180 150 330 25 Clofazimine (Cfz) 100 mg 0 1 1 180 150 330 29.47 Pyrazinamide (Z) 500 mg 2 3 4 180 150 330 0.98 Isoniazid (H high-dose ) 300 mg 1 1 2 180 0 180 0.6 Isoniazid (H high-dose ) 100 mg 1 180 0 180 0.19 Ethambutol (E) 400 mg 2 2 3 180 150 330 0.89 4. 2à¸¹!10@ 6Bdq- Lfx - Pto -Cfz-Z-H high-dose -E/5 Lfx -Cfx-Z-E 24 à¸­à¸²à¸—à¸´0à¹Œ Oà¸­/à¸¹à¸¥1@à¸„@0@1?1@/?P1à¸„ à¸· à¸­0@à¸«à¸¥@0@ 2à¸¹!10@1>0>2? Oral STR (Oral Shorter Regimen) Q!1>Nà¸—0Rà¸—0 à¸ž1Oà¸­/Oà¸«à¸¥Nà¸­O@à¸­>1@à¸„@ Powered by TCPDF (www.tcpdf.org)
